Identifying predictive markers for survival in malignant biliary obstruction following percutaneous transhepatic biliary drainage

被引:0
作者
Chan, K. [1 ]
Vigneswaran, G. [1 ,2 ]
Modi, S. [1 ]
Hee, C. Sew [1 ]
Maclean, D. [1 ]
Stedman, B. [1 ]
Bryant, T. [1 ]
Maher, B. [1 ]
机构
[1] Southampton Gen Hosp, Univ Hosp Southampton, Tremona Rd, Southampton SO16 6YD, Hants, England
[2] Univ Southampton, Canc Sci, Univ Rd, Southampton SO17 1BJ, Hants, England
关键词
D O I
10.1016/j.crad.2024.106772
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: Malignant biliary obstructive disease is commonly managed with percutaneous transhepatic biliary drainage (PTBD). Traditionally, outcomes are evaluated collectively despite substantial variability in the underlying aetiology and extent of disease. The purpose of this study was to investigate whether variability in survival could be explained by different underlying patient and disease factors. MATERIALS AND METHODS: A single centre, retrospective study was performed looking at first-time malignant PTBD and respective survival outcomes between 2017- 2021. Survival censoring was taken as June 2022. Predictors included aetiology, age, preprocedural serum haemoglobin, and bilirubin. Subgroups were dichotomised with respect to median values. KaplaneMeier survival analysis and the log rank test were used for univariate analysis and Cox proportional hazards regression for multivariate analysis. RESULTS: One hundred fifty-six patients were identified, including 62 pancreatic, 19 ampullary/duodenal, 55 hilar cholangiocarcinoma, and 20 non hepatobiliary cancers. Median overall survival for the entire cohort was 136 days. The underlying aetiology significantly impacted median survival with non-hepatobiliary obstruction faring the worst; 53 days, and was in stark contrast to cholangiocarcinoma (347 days, p < 0.001). On multivariate analysis, we found that in addition to aetiology, patients > 70 years, preprocedural haemoglobin (< 110) and bilirubin (> 232) were all independent prognosticators and had significantly worse survival (HR 1.2, 1.8, 1.6, and 1.4, respectively, all p < 0.05). CONCLUSION: Age, underlying malignant aetiology, preprocedural haemoglobin, and bilirubin were identified as independent predictors of post-PTBD survival. Careful patient selection may therefore improve patient outcomes following PTBD. (c) 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:8
相关论文
共 14 条
[1]  
[Anonymous], 2021, 8. Bordoni B, Varacallo M. Anatomy, Head and Neck, Temporomandibular Joint [Internet]. Treasure Island (FL): StatPearls
[2]  
2021. [cited 2022 Jan 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538486/
[3]   Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy? [J].
Dolejs, Scott ;
Zarzaur, Ben L. ;
Zyromski, Nicholas J. ;
Pitt, Henry A. ;
Riall, Taylor S. ;
Hall, Bruce L. ;
Behrman, Stephen W. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (04) :647-656
[4]   Clinical Performance Status and Technical Factors Affecting Outcomes from Percutaneous Transhepatic Biliary Interventions; A Multicentre, Prospective, Observational Cohort Study [J].
Makris, Gregory C. ;
Macdonald, Andrew C. ;
Allouni, Kader ;
Corrigall, Hannah ;
Tapping, Charles R. ;
Hughes, Jane Philips ;
Anthony, Suzie ;
Boardman, Phil ;
Patel, Rafiudin ;
Wigham, Andrew ;
Husainy, Mohammad Ali ;
See, Teik Choon ;
Cast, James ;
Olliff, Simon ;
Travis, Simon ;
Laasch, Hans-Ulrich ;
Nice, Colin ;
Uberoi, Raman .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (10) :1625-1632
[5]   Is Palliative Percutaneous Drainage for Malignant Biliary Obstruction Useful? [J].
Niemela, Jarmo ;
Kallio, Raija ;
Ohtonen, Pasi ;
Perala, Jukka ;
Saarnio, Juha ;
Syrjala, Hannu .
WORLD JOURNAL OF SURGERY, 2018, 42 (09) :2980-2986
[6]   The Clinical Benefit of Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Tract Obstruction [J].
Nikolic, Ivan ;
Radic, Jelena ;
Petres, Andrej ;
Djuric, Aleksandar ;
Protic, Mladjan ;
Litavski, Jelena ;
Popovic, Maja ;
Kolarov-Bjelobrk, Ivana ;
Dragin, Sasa ;
Popovic, Lazar .
CANCERS, 2022, 14 (19)
[7]   The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study [J].
Rees, James ;
Mytton, Jemma ;
Evison, Felicity ;
Mangat, Kamarjit Singh ;
Patel, Prashant ;
Trudgill, Nigel .
BMJ OPEN, 2020, 10 (01)
[8]   Prospective Study of Outcomes after Percutaneous Biliary Drainage for Malignant Biliary Obstruction [J].
Robson, P. C. ;
Heffernan, N. ;
Gonen, M. ;
Thornton, R. ;
Brody, L. A. ;
Holmes, R. ;
Brown, K. T. ;
Covey, A. M. ;
Fleischer, D. ;
Getrajdman, G. I. ;
Jarnagin, W. ;
Sofocleous, C. ;
Blumgart, L. ;
D'Angelica, M. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) :2303-2311
[9]   Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience [J].
Sahinli, Hayriye ;
Ozet, Ahmet .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 :S99-S103
[10]   A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage [J].
Sha, Junfeng ;
Dong, Yanchao ;
Niu, Hongtao .
MEDICINE, 2019, 98 (15)